Estimating Breast Cancer-Specific and Other Cause Mortality in Clinical Trial and Population-Based Cancer Registry Cohorts
2009
Background
To compute net cancer-specific survival rates using population data sources (e.g., Surveillance, Epidemiology and End Results (SEER)), two approaches are primarily used: relative survival (observed survival adjusted for life expectancy) and cause-specific survival based on death certificates. We evaluate the performance of these estimates relative to a third approach based on detailed clinical follow-up history.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
23
References
45
Citations
NaN
KQI